Currently, novel proteomic techniques, especially the stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics [25], offer possibility of systematically investigating the expression profiling of different HSP members in glioma in terms of quantitative view. The gene discussed is HSP90B2P; the disease is central nervous system cancer.